Maryland Cannabis Legalization Virtual Press Conference
Del. Jazz Lewis and a broad coalition, including DFCR spokesperson Dr. Ralph Salvagno, and other advocates, call for the passage of HB 32 via a virtual press conference.
Category Archives: DFCR
Continue reading
N.J. should allow medical patients, low-wage earners to grown their own marijuana
DFCR Founder and President David Nathan authors an opinion piece regarding home grow rights in New Jersey.
Bryon Adinoff – Texas Veterans Service Related Injuries and Cannabis Treatment Panel
DFCR Executive Vice President, Dr. Bryon Adinoff spoke with other panelists during the Texas Marijuana Policy Conference hosted by Texans for Responsible Marijuana Policy regarding veteran service related injuries and cannabis treatment. Watch the entire panel and others on demand […]
Doctors for Cannabis Regulation (DFCR) Statement on Cannabis Use During Pregnancy and Breastfeeding
Doctors for Cannabis Regulation (DFCR) Statement on Cannabis Use During Pregnancy and Breastfeeding
Call for Papers – Medical Cannabis in Professional Education
DFCR experts Mikhail Kogan, MD and Leslie Mendoza Temple, MD serve as guest editors for Elsevier’s Complementary Therapies in Medicine. With the growing trend in legalization and increased patient use of medical cannabis, students of health professions are likely to […]
Cannabis Influencers: Call on this doctor for the answers about the plant’s potential
Article excerpt Monica Taing talks very fast. Enthusiasm is her accelerator pedal as the 29-year-old pharmacist from Jersey City describes cannabis’ potential to expand the options for chronically ill people — especially those who are leery of using addictive opioids […]
Delta-8-THC: Scientists explain the cannabis industry’s “latest hype”
Article excerpt: Peter Grinspoon is a primary care physician at Harvard Medical School. He’s also on the board of the advocacy group, Doctors for Cannabis Regulation. He tells Inverse that Delta-8-THC does have “vast” potential, as do many of the […]
Don’t forget to turn the page and legalize marijuana
Article excerpt: “Do you approve of amending the Constitution to legalize a controlled form of marijuana called ‘cannabis’? Only adults at least 21 years of age could use cannabis. The State commission created to oversee the State’s medical cannabis program […]
Cannabis influencers: Doctor of Reform
Article excerpt: This story is part of a series of profiles, The CannaInfluencers: The people shaping the cannabis industry in the Garden State. Written by NJ Cannabis Insider reporters, the profiles will publish in the weeks leading up to the […]
The cannabis market already exists. Let’s regulate it.
DFCR Founder and President David Nathan co-authors an opinion piece with Paul Armentano regarding the upcoming vote to legalize cannabis in New Jersey. Article excerpt: Having spent many years working on marijuana policy, we’ve had ringside seats to the dramatic […]
Cannabis specialist Dr Peter Grinspoon explores education and policy in US addiction treatment
Article excerpt: Dr Peter Grinspoon is a primary care physician, an instructor at Harvard Medical School, and a contributing editor to Harvard Health Publications. In his capacity as a specialist authority on addiction and medical cannabis, he has served as […]
What do doctors, nurses need to know about N.J.’s medical marijuana program, legalization?
Article excerpt: Despite being signed into law in July 2019, many of the improvements touted by Jake Honig’s Law, which expanded the state’s medical marijuana program, have yet to be implemented, frustrating physicians, healthcare professionals and attorneys operating in the […]
DFCR Expert Mikhail Kogan Responds to New Guidelines for use of Medical Cannabis for Chronic Pain
Recently new guidelines were issued on medical cannabis for chronic pain. An excerpt: Chronic pain patients can be treated with medical cannabis following one of three protocols based on patient characteristics, according to an international task force at the virtual […]
Delta-8-THC Promises to Get You High Without the Paranoia or Anxiety
Article excerpt: Delta-9-THC, the main drug in cannabis plants that gets people high, can also be a potent medicine. It can treat extreme nausea and stimulate appetite, which is especially helpful for people who have HIV or are going through […]
Setting the Standard for Cannabis Labeling
David L. Nathan, MD on introducing the Universal Cannabis Product Symbol and the Universal Cannabis Information Label at Cannabis Science and Technology. Read the article at Cannabis Science and Technology
Drug Policy Alliance Leads Extensive Coalition of Public Health Organizations and Professionals in Calling on Congress to Support Marijuana Reform
Washington, D.C. – Today, the Drug Policy Alliance (DPA) led a group of 16 public health organizations and over 100 public health professionals in calling on members of Congress to support comprehensive marijuana reform by bringing the Marijuana Opportunity Reinvestment & Expungement […]
Local leadership speak out in opposition to Missouri medical marijuana initiative
From the article: When voters head to the polls in November two initiatives regarding the legalization of medical marijuana will appear. The first is Initiative 65, which was brought forward by the citizens of Mississippi who would like to see […]
CBG May Be The New CBD
Article excerpt: “CBG is interesting in a lot of different ways,” says Peter Grinspoon, MD, primary care physician at Massachusetts General Hospital, instructor at Harvard Medical School, and board member of the advocacy group Doctors For Cannabis Regulation. Dr. Grinspoon […]
The Science of the Endocannabinoid System
Originally appeared at the American Journal of Endocannabinoid Medicine
Building on Portland’s Vision of Equity: Q&A with Cannabis Program Supervisor Dasheeda Dawson
Article excerpt: Portland’s Office of Community & Civic Life named Dasheeda Dawson as its new cannabis program supervisor earlier this month, in some ways ushering in a new chapter of the city’s Social Equity Grant program. Portland voters passed a 3% […]